We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$265M
AUM Growth
+$1.61M
Cap. Flow
-$4.39M
Cap. Flow %
-1.66%
Top 10 Hldgs %
37.8%
Holding
155
New
33
Increased
20
Reduced
44
Closed
28

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.52M
2
CVS icon
CVS Health
CVS
+$4.51M
3
LHX icon
L3Harris
LHX
+$4.09M
4
CRM icon
Salesforce
CRM
+$3.6M
5
DLTR icon
Dollar Tree
DLTR
+$3.6M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.62M
2
V icon
Visa
V
+$5.01M
3
HUM icon
Humana
HUM
+$4.83M
4
DLR icon
Digital Realty Trust
DLR
+$4.27M
5
ROK icon
Rockwell Automation
ROK
+$4.18M

Sector Composition

Rank Sector Weight
1 Technology 36%
2 Healthcare 10.46%
3 Industrials 9.79%
4 Financials 9.61%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
51
Exelon
EXC
$45.9B
$1.62M 0.61%
+46,859
New +$1.73M
SJM icon
52
J.M. Smucker
SJM
$12.6B
$1.56M 0.59%
+14,350
New +$1.62M
F icon
53
Ford
F
$56B
$1.54M 0.58%
+123,006
New +$1.52M
SHW icon
54
Sherwin-Williams
SHW
$88B
$1.54M 0.58%
+5,163
New +$1.6M
NDSN icon
55
Nordson
NDSN
$17.2B
$1.54M 0.58%
+6,626
New +$1.67M
CNA icon
56
CNA Financial
CNA
$13.8B
$1.41M 0.53%
30,636
-15,458
-34% -$686K
BAX icon
57
Baxter International
BAX
$14.4B
$1.32M 0.5%
+39,437
New +$1.45M
ORCL icon
58
Oracle
ORCL
$436B
$1.3M 0.49%
+9,214
New +$1.14M
T icon
59
AT&T
T
$165B
$1.26M 0.48%
66,191
-3,050
-4% -$53K
PCAR icon
60
PACCAR
PCAR
$68.8B
$1.26M 0.48%
12,253
-650
-5% -$71.7K
RTX icon
61
RTX Corp
RTX
$301B
$1.26M 0.48%
12,530
-650
-5% -$67.2K
CF icon
62
CF Industries
CF
$18.2B
$1.24M 0.47%
16,675
-900
-5% -$69.9K
NOW icon
63
ServiceNow
NOW
$131B
$1.23M 0.46%
7,810
-250
-3% -$36.7K
CMI icon
64
Cummins
CMI
$87.8B
$1.22M 0.46%
4,417
-175
-4% -$50K
HST icon
65
Host Hotels & Resorts
HST
$15.5B
$1.2M 0.46%
+66,937
New +$1.25M
HBAN icon
66
Huntington Bancshares
HBAN
$35.4B
$1.2M 0.45%
+90,871
New +$1.22M
LRCX icon
67
Lam Research
LRCX
$386B
$1.15M 0.43%
10,790
-500
-4% -$48K
WFC icon
68
Wells Fargo
WFC
$265B
$1.11M 0.42%
18,774
-29,160
-61% -$1.72M
ANET icon
69
Arista Networks
ANET
$242B
$1.11M 0.42%
12,664
– –
SBAC icon
70
SBA Communications
SBAC
$19.3B
$1.07M 0.4%
+5,458
New +$1.08M
DAL icon
71
Delta Air Lines
DAL
$59.1B
$1.06M 0.4%
22,370
– –
EOG icon
72
EOG Resources
EOG
$74.5B
$986K 0.37%
7,834
-500
-6% -$64.1K
SMCI icon
73
Super Micro Computer
SMCI
$20.5B
$977K 0.37%
11,930
+2,180
+22% +$186K
CCI icon
74
Crown Castle
CCI
$31.4B
$918K 0.35%
+9,397
New +$925K
C icon
75
Citigroup
C
$227B
$849K 0.32%
13,381
-1,300
-9% -$80.2K
1 2
3
4 5

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Stoneridge Investment Partners held 155 positions worth $265M, up 0.61% from $263M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stoneridge Investment Partners's Q2 2024 filing shows 33 new, 20 increased, 44 reduced and 28 closed positions. Its largest new stake was CVS Health: 72,169 shares worth $4.26M. The largest sale was Pfizer, an estimated $6.62M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Stoneridge Investment Partners's largest Q2 2024 buy was CVS Health: 72,169 shares worth $4.26M.
  • Stoneridge Investment Partners added most to Bristol-Myers Squibb in Q2 2024, an estimated $4.52M increase.
  • Stoneridge Investment Partners's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $2.39M.
  • Stoneridge Investment Partners fully exited Pfizer in Q2 2024, selling an estimated $6.62M.
  • Stoneridge Investment Partners's ten largest holdings make up 38% of its $265M portfolio in Q2 2024.
  • Stoneridge Investment Partners opened 33 new positions and closed 28 in Q2 2024.
  • Stoneridge Investment Partners's portfolio value rose 0.61% quarter-over-quarter to $265M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.